<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37725516</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2222-1751</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Emerging microbes &amp; infections</Title><ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation></Journal><ArticleTitle>Severe pneumonia and pathogenic damage in human airway epithelium caused by Coxsackievirus B4.</ArticleTitle><Pagination><StartPage>2261560</StartPage><MedlinePgn>2261560</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2261560</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/22221751.2023.2261560</ELocationID><Abstract><AbstractText>Coxsackievirus B4 (CVB4) has one of the highest proportions of fatal outcomes of other enterovirus serotypes. However, the pathogenesis of severe respiratory disease caused by CVB4 infection remains unclear. In this study, 3 of 42 (7.2%, GZ-R6, GZ-R7 and GZ-R8) patients with severe pneumonia tested positive for CVB4 infection in southern China. Three full-length genomes of pneumonia-derived CVB4 were sequenced and annotated for the first time, showing their high nucleotide similarity and clustering within genotype V. To analyze the pathogenic damage caused by CVB4 in the lungs, a well-differentiated human airway epithelium (HAE) was established and infected with the pneumonia-derived CVB4 isolate GZ-R6. The outcome was compared with that of a severe hand-foot-mouth disease (HFMD)-derived CVB4 strain GZ-HFM01. Compared with HFMD-derived CVB4, pneumonia-derived CVB4 caused more intense and rapid disruption of HAE polarity, leading to tight-junction barrier disruption, loss of cilia, and airway epithelial cell hypertrophy. More pneumonia-derived CVB4 were released from the basolateral side of the HAE than HFMD-derived CVB4. Of the 18 cytokines tested, only IL-6 and IL-1b secretion significantly increased on bilateral sides of HAE during the early stage of pneumonia-derived CVB4 infection, while multiple cytokine secretions significantly increased in HFMD-derived CVB4-infected HAE. HFMD-derived CVB4 exhibited stronger neurovirulence in the human neuroblastoma cells SH-SY5Y than pneumonia-derived CVB4, which is consistent with the clinical manifestations of patients infected with these two viruses. This study has increased the depth of our knowledge of severe pneumonia infection caused by CVB4 and will benefit its prevention and treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Duo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The Center for Microbes, Development and Health, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Huan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Scientific Research Center, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Dehui</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Zhengshi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Shuyan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Xingui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Scientific Research Center, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Yujun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wenkuan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Microbes Infect</MedlineTA><NlmUniqueID>101594885</NlmUniqueID><ISSNLinking>2222-1751</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009447" MajorTopicYN="Y">Neuroblastoma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="Y">Pneumonia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004848" MajorTopicYN="N">Epithelium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coxsackievirus B4</Keyword><Keyword MajorTopicYN="N">full-length genome</Keyword><Keyword MajorTopicYN="N">hand-foot-mouth disease (HFMD)</Keyword><Keyword MajorTopicYN="N">human airway epithelium</Keyword><Keyword MajorTopicYN="N">neurovirulence</Keyword><Keyword MajorTopicYN="N">pathogenic damage</Keyword><Keyword MajorTopicYN="N">severe pneumonia</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>19</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>19</Day><Hour>12</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37725516</ArticleId><ArticleId IdType="pmc">PMC10538465</ArticleId><ArticleId IdType="doi">10.1080/22221751.2023.2261560</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zell R, Delwart E, Gorbalenya AE, et al. . ICTV virus taxonomy profile: picornaviridae. J Gen Virol. 2017 Oct;98(10):2421–2422. doi:10.1099/jgv.0.000911</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000911</ArticleId><ArticleId IdType="pmc">PMC5725991</ArticleId><ArticleId IdType="pubmed">28884666</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin J, Mangale V, Thienphrapa W, et al. . Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis. Virology. 2015 Oct;484:288–304. doi:10.1016/j.virol.2015.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.06.006</ArticleId><ArticleId IdType="pmc">PMC4567421</ArticleId><ArticleId IdType="pubmed">26142496</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowell RL, Landau BJ.. A short history and introductory background on the coxsackieviruses of group B. Curr Top Microbiol Immunol. 1997;223:1–11.</Citation><ArticleIdList><ArticleId IdType="pubmed">9294922</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Li J, Yao MX, et al. . Genome analysis of coxsackievirus A4 isolates from hand, foot, and mouth disease cases in shandong, China. Front Microbiol. 2019;10:1001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6513881</ArticleId><ArticleId IdType="pubmed">31134033</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau SKP, Zhao PSH, Sridhar S, et al. . Molecular epidemiology of coxsackievirus A6 circulating in Hong Kong reveals common neurological manifestations and emergence of novel recombinant groups. J Clin Virol. 2018 Nov;108:43–49. doi:10.1016/j.jcv.2018.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.09.002</ArticleId><ArticleId IdType="pubmed">30237097</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SH, Wang A, Liu PP, et al. . Divergent pathogenic properties of circulating coxsackievirus A6 associated with emerging hand, foot, and mouth disease. J Virol. 2018 Jun 1;92(11).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5952127</ArticleId><ArticleId IdType="pubmed">29563294</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YF, Yang F, Du J, et al. . Complete genome analysis of coxsackievirus A2, A4, A5, and A10 strains isolated from hand, foot, and mouth disease patients in China revealing frequent recombination of human enterovirus A. J Clin Microbiol. 2011 Jul;49(7):2426–2434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3147834</ArticleId><ArticleId IdType="pubmed">21543560</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekoua MP, Alidjinou EK, Hober D.. Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus. Nat Rev Endocrinol. 2022 Aug;18(8):503–516. doi:10.1038/s41574-022-00688-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-022-00688-1</ArticleId><ArticleId IdType="pmc">PMC9157043</ArticleId><ArticleId IdType="pubmed">35650334</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam PE. Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease. Viral Immunol. 2006 Summer;19(2):133–146.</Citation><ArticleIdList><ArticleId IdType="pubmed">16817756</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulders MN, Salminen M, Kalkkinen N, et al. . Molecular epidemiology of coxsackievirus B4 and disclosure of the correct VP1/2Apro cleavage site: evidence for high genomic diversity and long-term endemicity of distinct genotypes. J Gen Virol. 2000 Mar;81(Pt 3):803–812. doi:10.1099/0022-1317-81-3-803</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-81-3-803</ArticleId><ArticleId IdType="pubmed">10675418</ArticleId></ArticleIdList></Reference><Reference><Citation>Khetsuriani N, Lamonte-Fowlkes A, Oberst S, et al. . Enterovirus surveillance–United States, 1970-2005. MMWR Surveill Summ. 2006 Sep 15;55(8):1–20.</Citation><ArticleIdList><ArticleId IdType="pubmed">16971890</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaidane H, Hober D.. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab. 2008 Dec;34–6(Pt 1):537–548.</Citation><ArticleIdList><ArticleId IdType="pubmed">18951821</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian X, Zhang Y, Gu S, et al. . New coxsackievirus B4 genotype circulating in Inner Mongolia autonomous region, China. PLoS One. 2014;9(3):e90379), doi:10.1371/journal.pone.0090379</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0090379</ArticleId><ArticleId IdType="pmc">PMC3940859</ArticleId><ArticleId IdType="pubmed">24595311</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J, Wang J, Zhang Y, et al. . Coxsackievirus B4: an underestimated pathogen associated with a hand, foot, and mouth disease outbreak. Arch Virol. 2021 Jun 6.</Citation><ArticleIdList><ArticleId IdType="pubmed">34091782</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon JW, Austin M, Onodera T, et al. . Virus-Induced diabetes mellitus. N Engl J Med. 1979 May 24;300(21):1173–1179. doi:10.1056/NEJM197905243002102</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197905243002102</ArticleId><ArticleId IdType="pubmed">219345</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray CG, Plexico KL, Wenner HA, et al. . Acute respiratory illness associated with coxsackie B4 virus in children. Pediatrics. 1967 Feb;39(2):220–226. doi:10.1542/peds.39.2.220</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.39.2.220</ArticleId><ArticleId IdType="pubmed">6017958</ArticleId></ArticleIdList></Reference><Reference><Citation>Hierholzer JC, Mostow SR, Dowdle WR.. Prospective study of a mixed coxsackie virus B3 and B4 outbreak of upper respiratory illness in a children's home. Pediatrics. 1972 May;49(5):744–752. doi:10.1542/peds.49.5.744</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.49.5.744</ArticleId><ArticleId IdType="pubmed">5035418</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien YS, Luo ST, Tsao KC, et al. . Genomic analysis of serologically untypable human enteroviruses in Taiwan. J Biomed Sci. 2019 Jul 3;26(1):49, doi:10.1186/s12929-019-0541-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0541-x</ArticleId><ArticleId IdType="pmc">PMC6607526</ArticleId><ArticleId IdType="pubmed">31266491</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkahla MA, Alidjinou EK, Sane F, et al. . Fluoxetine can inhibit coxsackievirus-B4 E2 in vitro and in vivo. Antiviral Res. 2018 Nov;159:130–133. doi:10.1016/j.antiviral.2018.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2018.10.002</ArticleId><ArticleId IdType="pubmed">30290197</ArticleId></ArticleIdList></Reference><Reference><Citation>Alidjinou EK, Sane F, Bertin A, et al. . Persistent infection of human pancreatic cells with Coxsackievirus B4 is cured by fluoxetine. Antiviral Res. 2015 Apr;116:51–54. doi:10.1016/j.antiviral.2015.01.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2015.01.010</ArticleId><ArticleId IdType="pubmed">25655448</ArticleId></ArticleIdList></Reference><Reference><Citation>Kfoury KA E, Romond MB, Scuotto A, et al. . Bifidobacteria-derived lipoproteins inhibit infection with coxsackievirus B4 in vitro. Int J Antimicrob Agents. 2017 Aug;50(2):177–185. doi:10.1016/j.ijantimicag.2017.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2017.03.010</ArticleId><ArticleId IdType="pubmed">28595938</ArticleId></ArticleIdList></Reference><Reference><Citation>Arena MP, Elmastour F, Sane F, et al. . Inhibition of coxsackievirus B4 by Lactobacillus plantarum. Microbiol Res. 2018 May;210:59–64. doi:10.1016/j.micres.2018.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micres.2018.03.008</ArticleId><ArticleId IdType="pubmed">29625659</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Pan Y, Chen J, et al. . A coxsackie B4 virus isolated in yunnan in 2009 is a recombinant. Virus Genes. 2015 Jun;50(3):375–380. doi:10.1007/s11262-015-1185-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-015-1185-x</ArticleId><ArticleId IdType="pubmed">25725901</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J, Wang J, Lu H, et al. . Genomic epidemiology and transmission dynamics of global coxsackievirus B4. Viruses. 2023 Feb 19;15(2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9961479</ArticleId><ArticleId IdType="pubmed">36851788</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan ZL, Lyu LK, Xie T, et al. . An imported genotype D coxsackievirus B4 strain identified in Tianjin, China. Biomed Environ Sci. 2022 Mar 20;35(3):239–247.</Citation><ArticleIdList><ArticleId IdType="pubmed">35317904</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean P, Florin TA.. Factors associated With pneumonia severity in children: A systematic review. J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):323–334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6454831</ArticleId><ArticleId IdType="pubmed">29850828</ArticleId></ArticleIdList></Reference><Reference><Citation>Pneumonia Etiology Research for Child Health Study G . Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet. 2019 Aug 31;394(10200):757–779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6727070</ArticleId><ArticleId IdType="pubmed">31257127</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Qiu S, Zhang L, et al. . Analysis of severe human adenovirus infection outbreak in guangdong province, southern China in 2019. Virol Sin. 2022 Jan 17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9243629</ArticleId><ArticleId IdType="pubmed">35307598</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu WK, Liu Q, Chen de H, et al. . Epidemiology of acute respiratory infections in children in Guangzhou: a three-year study. PLoS One. 2014;9(5):e96674), doi:10.1371/journal.pone.0096674</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0096674</ArticleId><ArticleId IdType="pmc">PMC4010508</ArticleId><ArticleId IdType="pubmed">24797911</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Chen D, Tan W, et al. . Epidemiology and clinical presentations of respiratory syncytial virus subgroups A and B detected with multiplex real-time PCR. PLoS One. 2016;11(10):e0165108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5072546</ArticleId><ArticleId IdType="pubmed">27764220</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamura K, Peterson D, Peterson N, et al. . MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011 Oct;28(10):2731–2739. doi:10.1093/molbev/msr121</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msr121</ArticleId><ArticleId IdType="pmc">PMC3203626</ArticleId><ArticleId IdType="pubmed">21546353</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu WK, Xu D, Xu Y, et al. . Protein profile of well-differentiated versus un-differentiated human bronchial/tracheal epithelial cells. Heliyon. 2020 Jun;6(6):e04243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7322050</ArticleId><ArticleId IdType="pubmed">32613119</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q, Deng X, Yan Z, et al. . Establishment of a reverse genetics system for studying human bocavirus in human airway epithelia. PLoS Pathog. 2012/09/08;ed2012:e1002899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3431310</ArticleId><ArticleId IdType="pubmed">22956907</ArticleId></ArticleIdList></Reference><Reference><Citation>Min KA, Rosania GR, Shin MC.. Human airway primary epithelial cells show distinct architectures on membrane supports under different culture conditions. Cell Biochem Biophys 2016 Jun;74(2):191–203. doi:10.1007/s12013-016-0719-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12013-016-0719-8</ArticleId><ArticleId IdType="pmc">PMC4903904</ArticleId><ArticleId IdType="pubmed">26818810</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiemstra PS, Grootaers G, van der Does AM, et al. . Human lung epithelial cell cultures for analysis of inhaled toxicants: lessons learned and future directions. Toxicol in Vitro. 2018;47:137–146. doi:10.1016/j.tiv.2017.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tiv.2017.11.005</ArticleId><ArticleId IdType="pubmed">29155131</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Chen Q, Zhang X, et al. . PCM1 recruits Plk1 to the pericentriolar matrix to promote primary cilia disassembly before mitotic entry. J Cell Sci. 2013 Mar 15;126(Pt 6):1355–1365.</Citation><ArticleIdList><ArticleId IdType="pubmed">23345402</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkoova B, Pospisilova M, Kramna L, et al. . Coxsackievirus B4 sewage-isolate induces pancreatitis after oral infection of mice. FEMS Microbiol Lett 2021 Aug 6;368(15), doi:10.1093/femsle/fnab092</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femsle/fnab092</ArticleId><ArticleId IdType="pmc">PMC8346287</ArticleId><ArticleId IdType="pubmed">34297106</ArticleId></ArticleIdList></Reference><Reference><Citation>Caggana M, Chan P, Ramsingh A.. Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J Virol 1993 Aug;67(8):4797–4803. doi:10.1128/jvi.67.8.4797-4803.1993</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.67.8.4797-4803.1993</ArticleId><ArticleId IdType="pmc">PMC237866</ArticleId><ArticleId IdType="pubmed">8392614</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsingh AI, Collins DN.. A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence. J Virol 1995 Nov;69(11):7278–7281. doi:10.1128/jvi.69.11.7278-7281.1995</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.69.11.7278-7281.1995</ArticleId><ArticleId IdType="pmc">PMC189653</ArticleId><ArticleId IdType="pubmed">7474153</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YF, Du J, Zhao R, et al. . Complete genome sequence of a recombinant coxsackievirus B4 from a patient with a fatal case of hand, foot, and mouth disease in guangxi, China. J Virol 2012 Oct;86(19):10901–2. doi:10.1128/JVI.01808-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01808-12</ArticleId><ArticleId IdType="pmc">PMC3457331</ArticleId><ArticleId IdType="pubmed">22966193</ArticleId></ArticleIdList></Reference><Reference><Citation>Porres ER, Werthammer J, Moss N, et al. . Fatal coxsackievirus B4 infection in a neonate. South Med J. 1985 Oct;78(10):1254–1256. doi:10.1097/00007611-198510000-00028</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007611-198510000-00028</ArticleId><ArticleId IdType="pubmed">2996154</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Wang H, Wei H, et al. . Genomic characteristics of coxsackievirus B4 isolated in henan province of China. Chinese Journal of Viral Diseases. 2018;8(1):33–38.</Citation></Reference><Reference><Citation>Crystal RG, Randell SH, Engelhardt JF, et al. . Airway epithelial cells: current concepts and challenges. Proc Am Thorac Soc. 2008 Sep 15;5(7):772–777. doi:10.1513/pats.200805-041HR</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/pats.200805-041HR</ArticleId><ArticleId IdType="pmc">PMC5820806</ArticleId><ArticleId IdType="pubmed">18757316</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles RJ. Human airway epithelial cell cultures for modeling respiratory syncytial virus infection. Curr Top Microbiol Immunol. 2013;372:371–387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7122615</ArticleId><ArticleId IdType="pubmed">24362700</ArticleId></ArticleIdList></Reference><Reference><Citation>Page H, Flood P, Reynaud EG.. Three-dimensional tissue cultures: current trends and beyond. Cell Tissue Res. 2013 Apr;352(1):123–131. doi:10.1007/s00441-012-1441-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-012-1441-5</ArticleId><ArticleId IdType="pubmed">22729488</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghapour M, Raee P, Moghaddam SJ, et al. . Airway epithelial barrier dysfunction in chronic obstructive pulmonary disease: role of cigarette smoke exposure. Am J Respir Cell Mol Biol. 2018 Feb;58(2):157–169. doi:10.1165/rcmb.2017-0200TR</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2017-0200TR</ArticleId><ArticleId IdType="pubmed">28933915</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Li C, Sachs N, et al. . Differentiated human airway organoids to assess infectivity of emerging influenza virus. Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):6822–6827. doi:10.1073/pnas.1806308115</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1806308115</ArticleId><ArticleId IdType="pmc">PMC6042130</ArticleId><ArticleId IdType="pubmed">29891677</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon Y, Hashimoto S.. Role of airway epithelial barrier dysfunction in pathogenesis of asthma. Allergol Int. 2018 Jan;67(1):12–17. doi:10.1016/j.alit.2017.08.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alit.2017.08.011</ArticleId><ArticleId IdType="pubmed">28941636</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Wang W, Liu Z, et al. . Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells. Nat Commun. 2020 Aug 6;11(1):3910, doi:10.1038/s41467-020-17796-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17796-z</ArticleId><ArticleId IdType="pmc">PMC7413383</ArticleId><ArticleId IdType="pubmed">32764693</ArticleId></ArticleIdList></Reference><Reference><Citation>Touzelet O, Broadbent L, Armstrong SD, et al. . The Secretome Profiling of a Pediatric Airway Epithelium Infected with hRSV Identified Aberrant Apical/Basolateral Trafficking and Novel Immune Modulating (CXCL6, CXCL16, CSF3) and Antiviral (CEACAM1) Proteins. Mol Cell Proteomics. 2020 May;19(5):793–807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7196588</ArticleId><ArticleId IdType="pubmed">32075873</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ZW, Zhuang ZC, Chen R, et al. . Enterovirus 71 VP1 protein regulates viral replication in SH-SY5Y cells via the mTOR autophagy signaling pathway. Viruses. 2019 Dec 20;12(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7019657</ArticleId><ArticleId IdType="pubmed">31861844</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang PY, Chong CWH, Alonso S.. Viral determinants that drive enterovirus-A71 fitness and virulence. Emerg Microbes Infect. 2021 Dec;10(1):713–724. doi:10.1080/22221751.2021.1906754</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1906754</ArticleId><ArticleId IdType="pmc">PMC8043536</ArticleId><ArticleId IdType="pubmed">33745413</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanyal SK, Mahdavy M, Gabrielson MO, et al. . Fatal myocarditis in an adolescent caused by coxsackie virus, group B, type four. Pediatrics. 1965 Jan;35:36–41. doi:10.1542/peds.35.1.36</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.35.1.36</ArticleId><ArticleId IdType="pubmed">14223222</ArticleId></ArticleIdList></Reference><Reference><Citation>Muto S, Miyoshi H, Nishikawa H, et al. . Novel recognition sequence of coxsackievirus 2A proteinase. Biochem Biophys Res Commun. 2006 Oct 6;348(4):1436–1442. doi:10.1016/j.bbrc.2006.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.08.012</ArticleId><ArticleId IdType="pubmed">16930558</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>